Clinical trial
Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle…
NCT00387621 · Horng Chen, Other · Completed
Key facts
| NCT number | NCT00387621 |
|---|---|
| Title | Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle Dysfunction |
| Official title | To Define in Normal Controls, Human Preclinical Systolic Dysfunction (PSD) and Preclinical Diastolic Dysfunction (PDD) the Actions of Acute Subcutaneous Nesiritide (BNP) on the Cardiorenal and Humoral Function and the Integrated Response to Acute Sodium Loading |
| Acronym | PPG1 |
| Lead sponsor | Horng Chen, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH National Center for Research Resources (NCRR) |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure |
| Intervention type | Drug |
| Interventions | Nesiritide, Placebo, Saline |
| Enrollment | 58 |
| Start date | Feb 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2009 |
| First posted | Oct 13, 2006 |
| Last update posted | May 17, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: